Blue-Chip

2 Stocks demonstrating some potential for 2018 - Insurance Australia and MNF

November 15, 2017 | Team Kalkine
2 Stocks demonstrating some potential for 2018 - Insurance Australia and MNF


Stocks’ Details
 

Insurance Australia Group Ltd

Forecasting low-single-digit growth in GWP for FY18:Insurance Australia Group Ltd (ASX: IAG) is forecasting low-single-digit growth in gross written premium for FY 2018 on an insurance margin in the range of 12.5%-14.5%. The guidance includes the ongoing rating response to short tail claims inflation, especially in motor. There is an assumption for further traction with commercial rates, in Australia and New Zealand. Moreover, the guidance also includes the loss of up to $60 million of gross written premium from exiting certain channels in the Swann business. Additionally, in FY17, IAG had posted GWP growth in line with the updated guidance the company had provided in February, in part due to better-than-expected retention rates in the commercial business. The company had reported margin of 14.9%, which was in the upper half range of the guidance IAG provided in June, and it had included the higher reserve releases than originally expected, which were partially offset by natural peril claims being $140m above expectations. Overall, the earnings’ growth over next couple of years can provide better returns. Meanwhile, IAG stock has risen 12.5% in six months as on November 14, 2017 and trades at a higher level. We maintain a “Hold” recommendation at the current price of $7.10
 

FY18 Outlook (Source: Company Reports)
 

MNF Group Ltd

Expects to deliver profit growth of 24% in FY18: MNF Group Ltd (ASX: MNF) in FY18 expects to deliver profit growth of 24% over the current financial year. The earnings per share is expected to come in at 20.5 cents which would represent growth of 18%. However, the forecasts still look low given the organic growth and impact from addition of any new client. The projection nevertheless includes the increase in expense for further substantial investment in the R&D resources to support strong growth well into the future. The increase in expense for additional office accommodation required for future growth has also been factored in. Meanwhile, MNF stock has risen 17.50% in three months as on November 14, 2017 and is trading at a very high price to earnings level. We give an “Expensive” recommendation on the stock at the current price of $5.72
 

FY18 Outlook (Source: Company Reports)
 


Disclaimer
 
The advice given by Kalkine Pty Ltd and provided on this website is general information only and it does not take into account your investment objectives, financial situation or needs. You should therefore consider whether the advice is appropriate to your investment objectives, financial situation and needs before acting upon it. You should seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice) as necessary before acting on any advice. Not all investments are appropriate for all people. Kalkine.com.au and associated pages are published by Kalkine Pty Ltd ABN 34 154 808 312 (Australian Financial Services License Number 425376). The information on this website has been prepared from a wide variety of sources, which Kalkine Pty Ltd, to the best of its knowledge and belief, considers accurate. You should make your own enquiries about any investments and we strongly suggest you seek advice before acting upon any recommendation. Kalkine Pty Ltd has made every effort to ensure the reliability of information contained in its newsletters and websites. All information represents our views at the date of publication and may change without notice. To the extent permitted by law, Kalkine Pty Ltd excludes all liability for any loss or damage arising from the use of this website and any information published (including any indirect or consequential loss, any data loss or data corruption). If the law prohibits this exclusion, Kalkine Pty Ltd hereby limits its liability, to the extent permitted by law to the resupply of services. There may be a product disclosure statement or other offer document for the securities and financial products we write about in Kalkine Reports. You should obtain a copy of the product disclosure statement or offer document before making any decision about whether to acquire the security or product. The link to our Terms & Conditions has been provided please go through them and also have a read of the Financial Services Guide. On the date of publishing this report (mentioned on the website), employees and/or associates of Kalkine Pty Ltd do not hold positions in any of the stocks covered on the website. These stocks can change any time and readers of the reports should not consider these stocks as advice or recommendations.